IP P®OSPE©TIVE

 PatentFreedom is a full service establishment offering subscription-based assistance in fighting the threat of non-practicing entities (NPE's).  NPE's are a growing threat to operating companies with patent portfolios of their own, in that NPE's don't hold their patents for core operational purposes, but instead use strategic enforcement activities such as licensing and litigation to turn a profit.  This use of patents has grown into a threatening phenomenon in the technology industries at an alarming rate.  PatentFreedom sets out to educate operating companies ... Read More

This week's IP Market Player is Royalty Pharma.  The name has begun to pop up in articles and conversations regarding attractive alternatives to raising equity capital. In a nutshell, the company purchases royalty interests in biopharmaceutical products and late-stage development drugs.  Through careful purchases, it provides liquidity to its shareholders investing in these royalty streams while assuming the risks of ownership in this IP.  This is an innovative product driven method of financing that is somewhat shielded from market volatility and stock price ... Read More